Zofia Jadwiga Leszczyńska
Research Subjects
Zofia Jadwiga Leszczyńska has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Agnieszka Benecka
Pomeranian Medical University in Szczecin
9 shared publications - Alicja Benecka
Prof. S. T. Dąbrowski Hospital in Puszczykowo S.A., 11 Józefa Ignacego Kraszewskiego Street, 62-040 Puszczykowo, Poland
9 shared publications - Iga Tartas
J. Strus City Multispecialty Hospital, Szwajcarska 3, 61-285 Poznań, Poland
9 shared publications - Jakub Pietrończyk
University Clinical Hospital in Poznań, Przybyszewskiego 49, 60-355 Poznań, Poland
9 shared publications - Krystian Kaczmarek
J. Strus City Multispecialty Hospital, Szwajcarska 3, 61-285 Poznań, Poland
9 shared publications - Natalia Prankiewicz
University Centre of Dentistry and Specialized Medicine, Bukowska 70, 60-812 Poznań, Poland
9 shared publications
Latest Publications
- Open Access
- 12 October 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (4(52))
CAFFEINE SUPPLEMENTATION AND ITS IMPACT ON EXERCISE PERFORMANCE AND COGNITIVE FUNCTION: A NARRATIVE REVIEW
Caffeine is one of the most widely consumed psychoactive substances and a well-established ergogenic aid in both athletic and cognitive performance contexts. The aim of this review was to evaluate the effects of caffeine supplementation on physical performance and cognitive function, with particular emphasis on dosage strategies, timing of ingestion, and individual variability in response. A narrative review of recent literature published between 2020 and 2025 was conducted using major scientific databases. The analysis included randomized controlled trials, systematic reviews, and meta-analyses investigating the impact of caffeine on exercise capacity, neuromuscular performance, and cognitive outcomes. The findings indicate that caffeine supplementation in doses ranging from 3 to 6 mg/kg body mass significantly enhances strength, power, and endurance performance. In addition, caffeine improves cognitive functions such as attention, reaction time, and alertness, particularly under conditions of fatigue. The ergogenic effects are primarily attributed to the antagonism of adenosine receptors and increased central nervous system stimulation. However, the response to caffeine varies considerably among individuals due to genetic factors, habitual intake, and sensitivity to stimulants. Excessive consumption may lead to adverse effects, including sleep disturbances, anxiety, and cardiovascular responses. In conclusion, caffeine represents an effective and accessible strategy for improving both physical and cognitive performance. Nevertheless, its optimal application requires individualized dosing, appropriate timing, and careful monitoring to maximize benefits while minimizing potential risks.
- 12 October 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (4(52))
Open AccessCAFFEINE SUPPLEMENTATION AND ITS IMPACT ON EXERCISE PERFORMANCE AND COGNITIVE FUNCTION: A NARRATIVE REVIEW
Caffeine is one of the most widely consumed psychoactive substances and a well-established ergogenic aid in both athletic and cognitive performance contexts. The aim of this review was to evaluate the effects of caffeine supplementation on physical performance and cognitive function, with particular emphasis on dosage strategies, timing of ingestion, and individual variability in response. A narrative review of recent literature published between 2020 and 2025 was conducted using major scientific databases. The analysis included randomized controlled trials, systematic reviews, and meta-analyses investigating the impact of caffeine on exercise capacity, neuromuscular performance, and cognitive outcomes. The findings indicate that caffeine supplementation in doses ranging from 3 to 6 mg/kg body mass significantly enhances strength, power, and endurance performance. In addition, caffeine improves cognitive functions such as attention, reaction time, and alertness, particularly under conditions of fatigue. The ergogenic effects are primarily attributed to the antagonism of adenosine receptors and increased central nervous system stimulation. However, the response to caffeine varies considerably among individuals due to genetic factors, habitual intake, and sensitivity to stimulants. Excessive consumption may lead to adverse effects, including sleep disturbances, anxiety, and cardiovascular responses. In conclusion, caffeine represents an effective and accessible strategy for improving both physical and cognitive performance. Nevertheless, its optimal application requires individualized dosing, appropriate timing, and careful monitoring to maximize benefits while minimizing potential risks.
- Open Access
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
CARDIORESPIRATORY FITNESS, VO2max, AND EXERCISE CAPACITY AS PREDICTORS OF CARDIOVASCULAR RISK AND MORTALITY: A NARRATIVE REVIEW
Background. Cardiovascular disease is one of the leading causes of morbidity and mortality worldwide. Physical inactivity and sedentary behavior are important modifiable risk factors. Cardiorespiratory fitness (CRF), often expressed as VO2max, VO2peak, metabolic equivalents (METs), exercise capacity, or estimated CRF, has gained attention as a predictor of cardiovascular and overall health. Aim. This review evaluated the prognostic significance of CRF in relation to cardiovascular risk, cardiovascular outcomes, cardiovascular mortality, all-cause mortality, and premature mortality in adults. Materials and methods. This narrative review was based on English-language publications identified in PubMed and Google Scholar. Meta-analyses, systematic reviews, observational cohort studies, clinical reviews, expert statements, and interventional studies relevant to cardiorespiratory fitness, exercise capacity, cardiovascular prevention, mortality, and cardiac rehabilitation were included in the synthesis. Results. The reviewed evidence consistently indicates that higher CRF is associated with a lower risk of all-cause mortality, cardiovascular mortality, and cardiovascular events. This relationship has been observed using various assessment methods, including directly measured VO2max or VO2peak, treadmill-derived peak METs, exercise capacity, and estimated CRF. CRF also appears to have prognostic value in populations with obesity, diabetes, hypertension, coronary artery disease, and heart failure. Changes in CRF over time may be associated with changes in mortality risk. These findings support the interpretation of CRF as a modifiable prognostic marker. Conclusions. CRF should be regarded as a measure of physical performance as well as an indicator of cardiovascular, respiratory, metabolic, and functional health. Its assessment may support cardiovascular risk stratification, prevention, and rehabilitation strategies in adult populations.
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
Open AccessCARDIORESPIRATORY FITNESS, VO2max, AND EXERCISE CAPACITY AS PREDICTORS OF CARDIOVASCULAR RISK AND MORTALITY: A NARRATIVE REVIEW
Background. Cardiovascular disease is one of the leading causes of morbidity and mortality worldwide. Physical inactivity and sedentary behavior are important modifiable risk factors. Cardiorespiratory fitness (CRF), often expressed as VO2max, VO2peak, metabolic equivalents (METs), exercise capacity, or estimated CRF, has gained attention as a predictor of cardiovascular and overall health. Aim. This review evaluated the prognostic significance of CRF in relation to cardiovascular risk, cardiovascular outcomes, cardiovascular mortality, all-cause mortality, and premature mortality in adults. Materials and methods. This narrative review was based on English-language publications identified in PubMed and Google Scholar. Meta-analyses, systematic reviews, observational cohort studies, clinical reviews, expert statements, and interventional studies relevant to cardiorespiratory fitness, exercise capacity, cardiovascular prevention, mortality, and cardiac rehabilitation were included in the synthesis. Results. The reviewed evidence consistently indicates that higher CRF is associated with a lower risk of all-cause mortality, cardiovascular mortality, and cardiovascular events. This relationship has been observed using various assessment methods, including directly measured VO2max or VO2peak, treadmill-derived peak METs, exercise capacity, and estimated CRF. CRF also appears to have prognostic value in populations with obesity, diabetes, hypertension, coronary artery disease, and heart failure. Changes in CRF over time may be associated with changes in mortality risk. These findings support the interpretation of CRF as a modifiable prognostic marker. Conclusions. CRF should be regarded as a measure of physical performance as well as an indicator of cardiovascular, respiratory, metabolic, and functional health. Its assessment may support cardiovascular risk stratification, prevention, and rehabilitation strategies in adult populations.
- Open Access
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
THE IMPACT OF PHYSICAL ACTIVITY ON SKIN AGING: THE ROLE OF OXIDATIVE STRESS AND ADAPTIVE MECHANISMS - NARRATIVE REVIEW
Skin aging is a multifactorial process driven by intrinsic mechanisms and environmental exposures, with oxidative stress playing a central role in cutaneous deterioration. Reactive oxygen species (ROS), generated both endogenously and through external factors such as ultraviolet radiation and pollution, contribute to collagen degradation, impaired barrier function, and structural skin damage. This narrative review summarizes current evidence regarding the relationship between physical activity and skin aging, with particular emphasis on oxidative stress–related mechanisms. Regular moderate exercise appears to have beneficial effects through improved cutaneous blood flow, enhanced antioxidant defense, mitochondrial adaptation, and stimulation of collagen-related pathways. Physical activity may also improve skin hydration, elasticity, and dermal structure. However, excessive or poorly adapted exercise may increase ROS production and inflammatory responses, potentially accelerating tissue damage. Outdoor physical activity additionally exposes the skin to environmental stressors, particularly UV, highlighting the importance of adequate photoprotection. Overall, the effects of exercise on skin aging appear dose-dependent and context-specific.
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
Open AccessTHE IMPACT OF PHYSICAL ACTIVITY ON SKIN AGING: THE ROLE OF OXIDATIVE STRESS AND ADAPTIVE MECHANISMS - NARRATIVE REVIEW
Skin aging is a multifactorial process driven by intrinsic mechanisms and environmental exposures, with oxidative stress playing a central role in cutaneous deterioration. Reactive oxygen species (ROS), generated both endogenously and through external factors such as ultraviolet radiation and pollution, contribute to collagen degradation, impaired barrier function, and structural skin damage. This narrative review summarizes current evidence regarding the relationship between physical activity and skin aging, with particular emphasis on oxidative stress–related mechanisms. Regular moderate exercise appears to have beneficial effects through improved cutaneous blood flow, enhanced antioxidant defense, mitochondrial adaptation, and stimulation of collagen-related pathways. Physical activity may also improve skin hydration, elasticity, and dermal structure. However, excessive or poorly adapted exercise may increase ROS production and inflammatory responses, potentially accelerating tissue damage. Outdoor physical activity additionally exposes the skin to environmental stressors, particularly UV, highlighting the importance of adequate photoprotection. Overall, the effects of exercise on skin aging appear dose-dependent and context-specific.
- Open Access
- 28 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
THYROID STORM IN PRIMARY CARE AND EMERGENCY DEPARTMENTS: A SYSTEMATIC REVIEW OF EARLY WARNING SIGNS AND STABILIZATION PROTOCOLS
Background: Thyroid storm is a rare but catastrophic endocrine emergency arising from decompensated, severe thyrotoxicosis. It triggers rapid multi-organ failure and carries a high mortality rate, particularly among critically ill patients and geriatric populations with significant comorbidities. Because its early constitutional signs are easily misattributed, frontline clinical vigilance is crucial for timely intervention. Aim: This review synthesizes early warning signs, precipitating stressors, diagnostic frameworks, and acute stabilization protocols to guide primary care and emergency clinicians. Materials and Methods: A systematic review of contemporary literature, clinical registries, and international guidelines published between 2016 and 2026 was conducted to evaluate clinical phenotypes, triggering factors, diagnostic criteria, and acute multi-targeted pharmacological strategies. Results: A thyroid storm is almost universally precipitated by acute secondary stressors, such as medication non-compliance, infections, surgery, or trauma. While younger populations typically present with a hyperkinetic phenotype (hyperthermia, severe tachycardia, and central nervous system agitation), elderly patients frequently display an atypical "apathetic" phenotype. This apathetic presentation lacks dramatic hypermetabolic features but carries a high risk of covert, life-threatening cardiac complications. From a diagnostic standpoint, the Japan Thyroid Association (JTA) guidelines mandate objective biochemical confirmation using a combinatory algorithm, whereas the Burch-Wartofsky Point Scale (BWPS) relies on a cumulative, symptom-weighted score. Emergency management requires a strict, multi-targeted pharmacological regimen: beta-blockers (propranolol or esmolol) for hyperadrenergic cardiotoxicity, thionamides to halt hormone synthesis, timed inorganic iodine to block hormone release, and glucocorticoids to counter relative adrenal insufficiency. Refractory circulatory collapse requires advanced extracorporeal rescue systems, including therapeutic plasma exchange (TPE) and Extracorporeal Membrane Oxygenation (ECMO). Conclusion: Combating the high mortality of a thyroid storm depends on a seamless, interprofessional continuum of care. Primary care physicians form the first line of defense through outpatient risk mitigation and medication optimization. When a crisis occurs, emergency clinicians must prioritize clinical acumen over rigid scoring algorithms, especially in apathetic presentations, to immediately initiate aggressive stabilization and secure prompt intensive care unit (ICU) containment.
- 28 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Open AccessTHYROID STORM IN PRIMARY CARE AND EMERGENCY DEPARTMENTS: A SYSTEMATIC REVIEW OF EARLY WARNING SIGNS AND STABILIZATION PROTOCOLS
Background: Thyroid storm is a rare but catastrophic endocrine emergency arising from decompensated, severe thyrotoxicosis. It triggers rapid multi-organ failure and carries a high mortality rate, particularly among critically ill patients and geriatric populations with significant comorbidities. Because its early constitutional signs are easily misattributed, frontline clinical vigilance is crucial for timely intervention. Aim: This review synthesizes early warning signs, precipitating stressors, diagnostic frameworks, and acute stabilization protocols to guide primary care and emergency clinicians. Materials and Methods: A systematic review of contemporary literature, clinical registries, and international guidelines published between 2016 and 2026 was conducted to evaluate clinical phenotypes, triggering factors, diagnostic criteria, and acute multi-targeted pharmacological strategies. Results: A thyroid storm is almost universally precipitated by acute secondary stressors, such as medication non-compliance, infections, surgery, or trauma. While younger populations typically present with a hyperkinetic phenotype (hyperthermia, severe tachycardia, and central nervous system agitation), elderly patients frequently display an atypical "apathetic" phenotype. This apathetic presentation lacks dramatic hypermetabolic features but carries a high risk of covert, life-threatening cardiac complications. From a diagnostic standpoint, the Japan Thyroid Association (JTA) guidelines mandate objective biochemical confirmation using a combinatory algorithm, whereas the Burch-Wartofsky Point Scale (BWPS) relies on a cumulative, symptom-weighted score. Emergency management requires a strict, multi-targeted pharmacological regimen: beta-blockers (propranolol or esmolol) for hyperadrenergic cardiotoxicity, thionamides to halt hormone synthesis, timed inorganic iodine to block hormone release, and glucocorticoids to counter relative adrenal insufficiency. Refractory circulatory collapse requires advanced extracorporeal rescue systems, including therapeutic plasma exchange (TPE) and Extracorporeal Membrane Oxygenation (ECMO). Conclusion: Combating the high mortality of a thyroid storm depends on a seamless, interprofessional continuum of care. Primary care physicians form the first line of defense through outpatient risk mitigation and medication optimization. When a crisis occurs, emergency clinicians must prioritize clinical acumen over rigid scoring algorithms, especially in apathetic presentations, to immediately initiate aggressive stabilization and secure prompt intensive care unit (ICU) containment.
- Open Access
- 28 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
TIZANIDINE IN THE MANAGEMENT OF MUSCULOSKELETAL PAIN, WITH PARTICULAR EMPHASIS ON BACK PAIN: MECHANISM OF ACTION, EFFICACY, SAFETY, AND CLINICAL USE – A LITERATURE REVIEW
Musculoskeletal pain, including back pain, is a leading cause of disability worldwide and often coexists with increased paraspinal muscle tension and painful muscle spasm. This narrative review aimed to summarize current knowledge on the mechanism of action, clinical efficacy, safety profile, and clinical use of tizanidine in musculoskeletal pain, with particular emphasis on back pain. The review included clinical trials, systematic reviews, case reports, clinical practice guidelines, prescribing information, and toxicological data concerning tizanidine. Tizanidine is a centrally acting alpha-2 adrenergic receptor agonist that inhibits polysynaptic spinal reflexes and exhibits both antispastic and antispasmodic effects, with possible involvement of imidazoline receptors. Earlier studies suggested that adding tizanidine to nonsteroidal anti-inflammatory drugs may improve outcomes in acute low back pain, whereas more recent randomized trials did not confirm additional clinical benefit. The most common adverse effects include drowsiness, dry mouth, hypotension, dizziness, and weakness. Rare but serious adverse effects include hallucinations, bradycardia, hepatotoxicity, and withdrawal symptoms after abrupt discontinuation. Strong CYP1A2 inhibitors, especially ciprofloxacin and fluvoxamine, markedly increase the risk of hypotension and excessive sedation. Evidence on the efficacy of tizanidine remains inconsistent. Tizanidine is not a first-line treatment but may be considered as short-term adjunctive therapy in selected patients when a muscular component is clinically relevant.
- 28 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Open AccessTIZANIDINE IN THE MANAGEMENT OF MUSCULOSKELETAL PAIN, WITH PARTICULAR EMPHASIS ON BACK PAIN: MECHANISM OF ACTION, EFFICACY, SAFETY, AND CLINICAL USE – A LITERATURE REVIEW
Musculoskeletal pain, including back pain, is a leading cause of disability worldwide and often coexists with increased paraspinal muscle tension and painful muscle spasm. This narrative review aimed to summarize current knowledge on the mechanism of action, clinical efficacy, safety profile, and clinical use of tizanidine in musculoskeletal pain, with particular emphasis on back pain. The review included clinical trials, systematic reviews, case reports, clinical practice guidelines, prescribing information, and toxicological data concerning tizanidine. Tizanidine is a centrally acting alpha-2 adrenergic receptor agonist that inhibits polysynaptic spinal reflexes and exhibits both antispastic and antispasmodic effects, with possible involvement of imidazoline receptors. Earlier studies suggested that adding tizanidine to nonsteroidal anti-inflammatory drugs may improve outcomes in acute low back pain, whereas more recent randomized trials did not confirm additional clinical benefit. The most common adverse effects include drowsiness, dry mouth, hypotension, dizziness, and weakness. Rare but serious adverse effects include hallucinations, bradycardia, hepatotoxicity, and withdrawal symptoms after abrupt discontinuation. Strong CYP1A2 inhibitors, especially ciprofloxacin and fluvoxamine, markedly increase the risk of hypotension and excessive sedation. Evidence on the efficacy of tizanidine remains inconsistent. Tizanidine is not a first-line treatment but may be considered as short-term adjunctive therapy in selected patients when a muscular component is clinically relevant.
- Open Access
- 28 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
THE BIDIRECTIONAL RELATIONSHIP BETWEEN DIABETES MELLITUS AND DEPRESSION: A SYSTEMATIC REVIEW OF BIOLOGICAL AND PSYCHOLOGICAL MECHANISMS
Diabetes mellitus and depression are two major global health challenges that frequently co-occur, with depression being two to three times more prevalent in individuals with diabetes than in the general population. Current evidence confirms a bidirectional relationship, where depression increases the risk of developing type 2 diabetes by 34%, and diabetes elevates the risk of incident depression by 28%. This systematic review explores the complex biological and psychological mechanisms underlying this interplay. Biological pathways include chronic low-grade inflammation characterized by elevated cytokines (IL-6, TNF-α, CRP), dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis resulting in hypercortisolemia, and impaired neuroplasticity linked to reduced levels of brain-derived neurotrophic factor (BDNF). Additionally, central insulin resistance and neurotransmitter alterations in serotonin and dopamine systems further exacerbate both conditions. Psychological and behavioral mediators include the specific emotional burden of diabetes distress, the significant self-management burden associated with insulin therapy and glucose monitoring, and lifestyle factors such as sedentary behavior, poor diet, and sleep disturbances. The presence of comorbid depression is a critical predictor of poor glycemic control (higher HbA1c), increased microvascular complications (retinopathy, nephropathy), and higher mortality rates. Consequently, clinical management must transition toward integrated, multidisciplinary care models that prioritize universal screening and collaborative treatment strategies. Future research should focus on longitudinal studies and the validation of biomarkers to enable precision medicine and improve the long-term prognosis for these patients.
- 28 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Open AccessTHE BIDIRECTIONAL RELATIONSHIP BETWEEN DIABETES MELLITUS AND DEPRESSION: A SYSTEMATIC REVIEW OF BIOLOGICAL AND PSYCHOLOGICAL MECHANISMS
Diabetes mellitus and depression are two major global health challenges that frequently co-occur, with depression being two to three times more prevalent in individuals with diabetes than in the general population. Current evidence confirms a bidirectional relationship, where depression increases the risk of developing type 2 diabetes by 34%, and diabetes elevates the risk of incident depression by 28%. This systematic review explores the complex biological and psychological mechanisms underlying this interplay. Biological pathways include chronic low-grade inflammation characterized by elevated cytokines (IL-6, TNF-α, CRP), dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis resulting in hypercortisolemia, and impaired neuroplasticity linked to reduced levels of brain-derived neurotrophic factor (BDNF). Additionally, central insulin resistance and neurotransmitter alterations in serotonin and dopamine systems further exacerbate both conditions. Psychological and behavioral mediators include the specific emotional burden of diabetes distress, the significant self-management burden associated with insulin therapy and glucose monitoring, and lifestyle factors such as sedentary behavior, poor diet, and sleep disturbances. The presence of comorbid depression is a critical predictor of poor glycemic control (higher HbA1c), increased microvascular complications (retinopathy, nephropathy), and higher mortality rates. Consequently, clinical management must transition toward integrated, multidisciplinary care models that prioritize universal screening and collaborative treatment strategies. Future research should focus on longitudinal studies and the validation of biomarkers to enable precision medicine and improve the long-term prognosis for these patients.
- Open Access
- 24 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
OPTIMAL DAILY PROTEIN INTAKE IN ATHLETES DURING MUSCLE MASS GAIN, FAT LOSS, AND BODY RECOMPOSITION: A LITERATURE REVIEW
Dietary protein plays a key role in training adaptations and body composition regulation, yet recommendations regarding optimal daily protein intake remain inconsistent. The aim of this review was to evaluate current evidence on optimal daily protein intake in athletes and resistance-trained individuals, with particular focus on increasing muscle mass, reducing fat mass, and body recomposition. The review was based on original studies, crossover trials, systematic reviews, meta-analyses, and expert position statements published within the last 15 years and available in PubMed. Studies assessing protein intake under conditions of energy balance, caloric surplus, and energy deficit were included, as well as publications addressing the distribution of protein intake throughout the day, protein source quality, and the long-term safety of high-protein diets. Available data indicate that protein intake should be tailored to the body composition goal. During muscle mass building, approximately 1.6–2.2 g/kg body mass/day appears sufficient to support hypertrophic adaptations and increase lean body mass. Higher intake usually does not provide clear additional anabolic benefits. During fat mass reduction, 1.8–2.4 g/kg body mass/day may more effectively limit muscle mass loss, maintain exercise capacity, and promote favorable body composition changes. For body recomposition, the range of 1.6–2.4 g/kg body mass/day appears most justified, particularly when combined with resistance training and controlled energy intake. Very high protein intake (>3 g/kg body mass/day) may additionally support fat mass reduction and improvement in body composition, but usually does not lead to distinctly greater muscle gains than moderately high intake. Protein intake in athletes should therefore be individualized according to the body composition goal and dietary energy conditions.
- 24 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Open AccessOPTIMAL DAILY PROTEIN INTAKE IN ATHLETES DURING MUSCLE MASS GAIN, FAT LOSS, AND BODY RECOMPOSITION: A LITERATURE REVIEW
Dietary protein plays a key role in training adaptations and body composition regulation, yet recommendations regarding optimal daily protein intake remain inconsistent. The aim of this review was to evaluate current evidence on optimal daily protein intake in athletes and resistance-trained individuals, with particular focus on increasing muscle mass, reducing fat mass, and body recomposition. The review was based on original studies, crossover trials, systematic reviews, meta-analyses, and expert position statements published within the last 15 years and available in PubMed. Studies assessing protein intake under conditions of energy balance, caloric surplus, and energy deficit were included, as well as publications addressing the distribution of protein intake throughout the day, protein source quality, and the long-term safety of high-protein diets. Available data indicate that protein intake should be tailored to the body composition goal. During muscle mass building, approximately 1.6–2.2 g/kg body mass/day appears sufficient to support hypertrophic adaptations and increase lean body mass. Higher intake usually does not provide clear additional anabolic benefits. During fat mass reduction, 1.8–2.4 g/kg body mass/day may more effectively limit muscle mass loss, maintain exercise capacity, and promote favorable body composition changes. For body recomposition, the range of 1.6–2.4 g/kg body mass/day appears most justified, particularly when combined with resistance training and controlled energy intake. Very high protein intake (>3 g/kg body mass/day) may additionally support fat mass reduction and improvement in body composition, but usually does not lead to distinctly greater muscle gains than moderately high intake. Protein intake in athletes should therefore be individualized according to the body composition goal and dietary energy conditions.
- Open Access
- 22 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 93
Ketamine and Esketamine in Depression: Current Evidence on Mechanisms, Efficacy, Safety and Clinical Use – A Review
Introduction and purpose. Major depressive disorder is a serious clinical problem. Current treatments are often unsuccessful, and many patients do not achieve full remission. In a reanalysis of the STAR*D study, the cumulative remission rate after up to four treatment steps was about 41%, which highlights the limitations of currently available antidepressant strategies[1]. In recent years, growing attention has been paid to novel agents with potential rapid antidepressant effects. Among them, ketamine and its derivatives have become the subject of numerous studies evaluating their role in depressive disorders, particularly in treatment-resistant depression [2]. The aim of this review is to summarize current evidence regarding the efficacy, safety, and clinical use of ketamine and its derivatives in depression, with particular emphasis on treatment-resistant depression. A brief description of the state of knowledge. This review presents current evidence on novel therapeutic agents that may be useful in the treatment of severe depression. It discusses the concept of severe depression and its broader clinical and social consequences. Particular attention is given to the mechanisms of action of ketamine and its derivatives, the available evidence on their efficacy, their adverse effects, and their potential impact on suicidal ideation. The review also emphasises the limitations of existing data and the need for further research. Summary (conclusions). Current data indicate that ketamine is a promising option for the treatment of drug-resistant and severe depression because of its rapid onset of action. Some evidence suggests that it may reduce suicidal ideation in high-risk patients, however further large-scale, long-term studies are needed to clarify the durability of benefit and long-term safety. [2,3,4].
- 22 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 93
Open AccessKetamine and Esketamine in Depression: Current Evidence on Mechanisms, Efficacy, Safety and Clinical Use – A Review
Introduction and purpose. Major depressive disorder is a serious clinical problem. Current treatments are often unsuccessful, and many patients do not achieve full remission. In a reanalysis of the STAR*D study, the cumulative remission rate after up to four treatment steps was about 41%, which highlights the limitations of currently available antidepressant strategies[1]. In recent years, growing attention has been paid to novel agents with potential rapid antidepressant effects. Among them, ketamine and its derivatives have become the subject of numerous studies evaluating their role in depressive disorders, particularly in treatment-resistant depression [2]. The aim of this review is to summarize current evidence regarding the efficacy, safety, and clinical use of ketamine and its derivatives in depression, with particular emphasis on treatment-resistant depression. A brief description of the state of knowledge. This review presents current evidence on novel therapeutic agents that may be useful in the treatment of severe depression. It discusses the concept of severe depression and its broader clinical and social consequences. Particular attention is given to the mechanisms of action of ketamine and its derivatives, the available evidence on their efficacy, their adverse effects, and their potential impact on suicidal ideation. The review also emphasises the limitations of existing data and the need for further research. Summary (conclusions). Current data indicate that ketamine is a promising option for the treatment of drug-resistant and severe depression because of its rapid onset of action. Some evidence suggests that it may reduce suicidal ideation in high-risk patients, however further large-scale, long-term studies are needed to clarify the durability of benefit and long-term safety. [2,3,4].
- Open Access
- 20 May 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 55, 71643
Intestinal Microbiota and Rheumatoid Arthritis: From Pathogenesis to Potential Therapies
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by progressive joint inflammation and multifactoral pathogenesis. Growing evidence indicates that the intestinal microbiota plays significant role in disease development and progression. Gut microbiota contributes to immune homeostasis, while dysbiosis-defined as altered microbial composition is associated with reduced diversity,expansion of pro-inflammatory taxa such as Prevotella copri and depletion of beneficial commensals. This review summarizes key mechanisms linking gut microbiota with RA, including increased intestinal permeability, immune dysregulation with Th17/Treg imbalance, molecular mimicry and altered production of microbial metabolites, particularly short-chain fatty acids. These processes are integrated within the concept of the gut-joint axis, explaining how intestinal disturbances may contribute to systemic and synovial inflammation. The potential of microbiota-derived biomarkers for diagnosis, prognosis and treatment response is also discussed. Additionally, emerging therapeutic strategies targeting gut microbiota, such as dietary interventions, probiotics and fecal microbiota transplantation are reviewed. Although promising, these approaches require further validation before clinical application.
- 20 May 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 55, 71643
Open AccessIntestinal Microbiota and Rheumatoid Arthritis: From Pathogenesis to Potential Therapies
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by progressive joint inflammation and multifactoral pathogenesis. Growing evidence indicates that the intestinal microbiota plays significant role in disease development and progression. Gut microbiota contributes to immune homeostasis, while dysbiosis-defined as altered microbial composition is associated with reduced diversity,expansion of pro-inflammatory taxa such as Prevotella copri and depletion of beneficial commensals. This review summarizes key mechanisms linking gut microbiota with RA, including increased intestinal permeability, immune dysregulation with Th17/Treg imbalance, molecular mimicry and altered production of microbial metabolites, particularly short-chain fatty acids. These processes are integrated within the concept of the gut-joint axis, explaining how intestinal disturbances may contribute to systemic and synovial inflammation. The potential of microbiota-derived biomarkers for diagnosis, prognosis and treatment response is also discussed. Additionally, emerging therapeutic strategies targeting gut microbiota, such as dietary interventions, probiotics and fecal microbiota transplantation are reviewed. Although promising, these approaches require further validation before clinical application.